The transition to EUDAMED is entering a new phase, and for medical device manufacturers, the preparation time is here.
While parts of EUDAMED adoption have operated under voluntary expectations, the shift toward mandatory requirements is accelerating. For regulatory teams, this moment is about more than checking a compliance box. It’s about building the data foundation, workflows, and internal readiness needed to support long-term EU regulatory compliance at scale.
In my conversation with Yuan Li, PhD Director of Medical Business of North America at DQS, we shared practical guidance on what manufacturers should be doing now to prepare for EUDAMED’s mandatory transition, reduce risk, and avoid last-minute disruption.
Below is a summary of the most important insights from the session, but watching the full webinar is essential for regulatory leaders managing EU submissions, compliance, and operational readiness.
What Is EUDAMED and Why Does the Transition Matter?
EUDAMED (European Database on Medical Devices) is the European Union’s centralized database designed to strengthen transparency, improve traceability, and support coordinated market surveillance across EU Member States.
As EUDAMED modules become mandatory, manufacturers will be expected to manage structured regulatory information across:
- Actor registration
- Device identification and UDI data
- Certificates
- Vigilance and post market surveillance activities
- Clinical related documentation and traceability elements
For manufacturers, the biggest challenge is not just understanding what needs to be submitted. It’s ensuring the right data is accessible, accurate, and ready to maintain over time.
The “Voluntary Period” Is a Strategic Opportunity
One of the strongest themes from the webinar was clear: even if certain components feel voluntary today, the smartest manufacturers are acting early.
Why? Because EUDAMED readiness isn’t something teams can rush through at the last minute. Early preparation gives regulatory teams time to:
- Validate internal device data and attributes
- Align stakeholders on ownership and governance
- Test workflows before high stakes deadlines
- Reduce rework caused by missing or inconsistent information
In other words, the voluntary period is not downtime. It’s your runway.
EUDAMED Readiness Starts with Data
A major insight Yuan and I shared was that EUDAMED implementation challenges often come down to one issue: data fragmentation
A key question regulatory leaders should ask now is:
Do we have a single source of truth for device and regulatory attributes?
EUDAMED Modules Are Connected, So Your Strategy Must Be Too
Another critical point covered in the webinar is that EUDAMED is not a series of isolated tasks. It’s an ecosystem.
Modules such as actor registration, device identification, certificates, and vigilance are designed to connect and reference each other. This means a gap in one area can quickly create downstream issues.
The webinar breaks down:
- How the modules relate
- What dependencies manufacturers often underestimate
- How to build an implementation roadmap that avoids bottlenecks
For teams supporting multiple product lines, regions, and device classifications, this interconnected structure makes planning essential.
Use the EUDAMED Practice Portal to Build Readiness Faster
The webinar strongly recommends using the EUDAMED practice environment (often referred to as the playground) as early as possible.
This is one of the most practical steps manufacturers can take because it allows teams to:
- Test workflows in a low risk environment
- Understand system behavior before real submissions
- Identify gaps in data fields and ownership
- Build internal confidence and speed
Legacy Products Require Special Attention
For manufacturers managing devices placed on the market under older frameworks, EUDAMED transition can be especially confusing.
The webinar provides helpful clarity on how requirements and timelines can vary depending on factors such as:
- Legacy device status
- When the product was placed on the market
- Identifier and data readiness
- Transition milestones and module availability
This portion of the session is especially relevant for regulatory teams responsible for large portfolios, where prioritization is essential.
This transition is not just about EU database requirements. It’s about modern regulatory operations. The full webinar provides detailed walkthroughs and implementation guidance that goes beyond high level summaries, including:
- What to do now during the voluntary period
- How to avoid common readiness mistakes
- How to prepare data and workflows at scale
- How EUDAMED changes compliance expectations long term
Learn how to build an EUDAMED readiness strategy that reduces risk, improves efficiency, and supports long term compliance.
To get the full context, timelines, and step by step guidance shared by RegDesk and DQS, watch the complete webinar recording for practical insights you can apply immediately.
